Helicobacter pylori is the first formally recognized bacterial carcinogen and is one of the
most successful human pathogens, as over half of the world's population is colonized with …

AIM: To assess the safety of bismuth used in Helicobacter pylori (H pylori) eradication
therapy regimens. METHODS: We conducted a systematic review and meta-analysis …

Antibiotic resistance is a major cause of Helicobacter pylori (H. pylori) treatment failures.
Because the resistance rate of H. pylori to furazolidone is low, we aimed to assess the …

Background: A standard third‐line treatment is lacking, and European guidelines
recommend performing culture in these patients. However, the use of this procedure as …

With the development of industry and human society, more attention was paid for the toxic
effects of organic pollutants that are closely related to human daily life. Previous studies …

Helicobacter pylori (H. pylori) infection is one of the most common bacterial infections,
affecting almost half of the world's population. It is associated with peptic ulcer disease …

Background & Aims: Antibiotic resistance is a major issue in anti–Helicobacter pylori
treatment. This study was aimed at assessing the efficacy of 2 therapies in patients with …

Objectives Furazolidone containing regimen is effectivefor Helicobacter pylori (H. pylori)
infection, but its safetyremains controversial. To assess the safety of furazolidone containing …

The combination of bismuth (III) citrate and the antibiotic furazolidone (FDZ) results in a
synergetic effect on Helicobacter pylori eradication. However, the problems associated with …

AIM To evaluate the outcomes of furazolidone-and amoxicillin-based quadruple therapy for
treatment of Helicobacter pylori (H. pylori) infection and identify predictors of failed …